placeholder image

H. Lena All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
    Lancet Oncology. 2018
    Article has an altmetric score of 133

    • Contact

    full name

  • H. Lena

    • Quick Info

    Publications

    Collaboration